Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Equecabtagene Autoleucel Injection (Eque-cel) in the Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)

NCT06902844 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06902844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06902844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Equecabtagene Autoleucel Injection (Eque-cel) in the Treatment of Relapsed/Refractory Systemic Lupus Erythematosus (SLE)
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
April 5, 2025
Completion date
January 10, 2028
Enrollment
6 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis (ln), systemic lupus erythematosus (sle)